Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.
Metrics to compare | IOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIOTPeersSector | |
---|---|---|---|---|
P/E Ratio | 23.5x | −3.7x | −0.5x | |
PEG Ratio | - | 0.04 | 0.00 | |
Price/Book | 3.5x | 1.1x | 2.6x | |
Price / LTM Sales | 3.0x | 2.2x | 2.9x | |
Upside (Analyst Target) | - | 173.8% | 45.8% | |
Fair Value Upside | Unlock | 6.9% | 8.6% | Unlock |